UY29401A1 - Clorhidato de lercanidipina amorfo. - Google Patents
Clorhidato de lercanidipina amorfo.Info
- Publication number
- UY29401A1 UY29401A1 UY29401A UY29401A UY29401A1 UY 29401 A1 UY29401 A1 UY 29401A1 UY 29401 A UY29401 A UY 29401A UY 29401 A UY29401 A UY 29401A UY 29401 A1 UY29401 A1 UY 29401A1
- Authority
- UY
- Uruguay
- Prior art keywords
- lercanidipine
- chlorhidate
- amorfo
- pure
- amorphous lercanidipine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C07B63/04—Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención proporciona un clorhidrato de lercanidipina amorfo sustancialmente puro con una pureza de por lo menos 95%, preferentemente por lo menos aproximadamente 97% puro, más preferentemente por lo menos aproximadamente 99% puro, y aun más preferentemente por lo menos aproximadamente 99,5% puro. La invención proporciona además métodos para preparar lercanidipina amorfo sustancialmete pura, y composiciones farmacéuticas que contienen la lercanidipina amorfo sustancialmente pura.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65683605P | 2005-02-25 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29401A1 true UY29401A1 (es) | 2006-06-30 |
Family
ID=36585434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29401A UY29401A1 (es) | 2005-02-25 | 2006-02-24 | Clorhidato de lercanidipina amorfo. |
Country Status (32)
Country | Link |
---|---|
US (1) | US7820701B2 (es) |
EP (1) | EP1856051B1 (es) |
JP (1) | JP2008531515A (es) |
KR (1) | KR20070105979A (es) |
CN (1) | CN101124204A (es) |
AR (1) | AR052918A1 (es) |
AU (1) | AU2006218026B9 (es) |
BR (1) | BRPI0608138A2 (es) |
CA (1) | CA2598016A1 (es) |
CY (1) | CY1122429T1 (es) |
DK (1) | DK1856051T3 (es) |
EA (1) | EA014383B1 (es) |
ES (1) | ES2339213T3 (es) |
HR (1) | HRP20192302T1 (es) |
HU (1) | HUE046910T2 (es) |
IL (1) | IL184349A0 (es) |
LT (1) | LT1856051T (es) |
ME (1) | ME03659B (es) |
MX (1) | MX2007010093A (es) |
MY (1) | MY142129A (es) |
NO (1) | NO344559B1 (es) |
NZ (1) | NZ556667A (es) |
PE (1) | PE20061014A1 (es) |
PL (1) | PL1856051T3 (es) |
PT (1) | PT1856051T (es) |
RS (1) | RS59654B1 (es) |
SI (1) | SI1856051T1 (es) |
TW (1) | TW200640861A (es) |
UA (1) | UA90130C2 (es) |
UY (1) | UY29401A1 (es) |
WO (1) | WO2006089787A1 (es) |
ZA (1) | ZA200708127B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60326961D1 (de) * | 2002-07-26 | 2009-05-14 | Novartis Vaccines & Diagnostic | Modifizierte kleine irns moleküle und methoden zu deren anwendung |
AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
AU2007280407B2 (en) * | 2006-08-04 | 2012-09-27 | Recordati Ireland Limited | Process for preparing amorphous lercanidipine hydrochloride |
WO2008068777A2 (en) * | 2006-12-06 | 2008-06-12 | Torrent Pharmaceuticals Limited | Stable lercanidipine formulation |
US20100104649A1 (en) * | 2007-03-05 | 2010-04-29 | Actavis Group Ptc Ehf | Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
AU2010247766B2 (en) * | 2009-05-12 | 2015-05-21 | Corcept Therapeutics, Inc. | Solid forms and process for preparing |
DE102010005124A1 (de) * | 2010-01-19 | 2012-03-01 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung umfassend Lercanidipin |
EP2444394A1 (en) | 2010-10-21 | 2012-04-25 | Alembic Pharmaceuticals Limited | Process for the preparation of amorphous form of lercanidipine HCI |
CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
CN102531999B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 无定形盐酸乐卡地平及其制备方法 |
CN102600146B (zh) * | 2012-04-11 | 2014-10-08 | 兆科药业(合肥)有限公司 | 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法 |
IN2013MU02828A (es) * | 2013-08-29 | 2015-07-03 | Cadila Healthcare Ltd |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
IT1274480B (it) | 1995-05-12 | 1997-07-17 | Recordati Chem Pharm | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
ITMI20011726A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
US6852737B2 (en) * | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
ITMI20011727A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
US20030069285A1 (en) * | 2001-08-06 | 2003-04-10 | Recordati Ireland Limited | Novel solvate and crystalline forms of lercanidipine hydrochloride |
US20030180355A1 (en) * | 2001-10-16 | 2003-09-25 | Amedeo Leonardi | Combination therapy for hypertension |
JP4749660B2 (ja) * | 2002-10-16 | 2011-08-17 | 武田薬品工業株式会社 | 安定な固形製剤 |
US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
WO2007054969A2 (en) | 2005-09-21 | 2007-05-18 | Torrent Pharmaceuticals Limited | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride |
AU2007280407B2 (en) | 2006-08-04 | 2012-09-27 | Recordati Ireland Limited | Process for preparing amorphous lercanidipine hydrochloride |
-
2006
- 2006-02-22 AR ARP060100641A patent/AR052918A1/es not_active Application Discontinuation
- 2006-02-24 MY MYPI20060808A patent/MY142129A/en unknown
- 2006-02-24 UY UY29401A patent/UY29401A1/es not_active Application Discontinuation
- 2006-02-24 DK DK06723128.2T patent/DK1856051T3/da active
- 2006-02-24 LT LTEP06723128.2T patent/LT1856051T/lt unknown
- 2006-02-24 EA EA200701687A patent/EA014383B1/ru unknown
- 2006-02-24 PL PL06723128T patent/PL1856051T3/pl unknown
- 2006-02-24 ES ES06723128T patent/ES2339213T3/es active Active
- 2006-02-24 NZ NZ556667A patent/NZ556667A/en not_active IP Right Cessation
- 2006-02-24 RS RS20191591A patent/RS59654B1/sr unknown
- 2006-02-24 SI SI200632364T patent/SI1856051T1/sl unknown
- 2006-02-24 PT PT67231282T patent/PT1856051T/pt unknown
- 2006-02-24 UA UAA200709786A patent/UA90130C2/ru unknown
- 2006-02-24 JP JP2007556565A patent/JP2008531515A/ja active Pending
- 2006-02-24 WO PCT/EP2006/001782 patent/WO2006089787A1/en active Application Filing
- 2006-02-24 BR BRPI0608138-0A patent/BRPI0608138A2/pt not_active Application Discontinuation
- 2006-02-24 KR KR1020077017758A patent/KR20070105979A/ko not_active Application Discontinuation
- 2006-02-24 ME MEP-2019-352A patent/ME03659B/me unknown
- 2006-02-24 CA CA002598016A patent/CA2598016A1/en not_active Abandoned
- 2006-02-24 CN CNA2006800054950A patent/CN101124204A/zh active Pending
- 2006-02-24 MX MX2007010093A patent/MX2007010093A/es not_active Application Discontinuation
- 2006-02-24 EP EP06723128.2A patent/EP1856051B1/en not_active Revoked
- 2006-02-24 TW TW095106337A patent/TW200640861A/zh unknown
- 2006-02-24 HU HUE06723128A patent/HUE046910T2/hu unknown
- 2006-02-24 AU AU2006218026A patent/AU2006218026B9/en not_active Ceased
- 2006-02-24 PE PE2006000224A patent/PE20061014A1/es active IP Right Grant
- 2006-02-27 US US11/364,862 patent/US7820701B2/en active Active
-
2007
- 2007-07-02 IL IL184349A patent/IL184349A0/en active IP Right Grant
- 2007-09-21 ZA ZA200708127A patent/ZA200708127B/xx unknown
- 2007-09-25 NO NO20074874A patent/NO344559B1/no not_active IP Right Cessation
-
2019
- 2019-12-18 CY CY20191101332T patent/CY1122429T1/el unknown
- 2019-12-20 HR HRP20192302TT patent/HRP20192302T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29401A1 (es) | Clorhidato de lercanidipina amorfo. | |
DK3219705T3 (da) | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid | |
CL2007001830A1 (es) | Compuestos derivados de isoindol; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de deterioro cognitivo, alzheimer, neurodegeneracion y demencia. | |
NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
ME02689B (me) | Novi kristalni oblik iii agomelatina, postupak za njegovu pripremu i farmaceutski preparati istog | |
BRPI0509184A (pt) | composições farmacêuticas | |
DK1845954T3 (da) | Oralt opløsende sammensætning af olanzapin og donepzil | |
SI1752443T1 (sl) | Nova kristalinična oblika V agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo | |
BRPI0816553A2 (pt) | "composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto" | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
BRPI0811712A2 (pt) | "composto, processo de preparação de um composto e composição farmacéutica". | |
ME02750B (me) | Kristalni oblik gama - d iv abradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže | |
ECSP066822A (es) | Macrólidos y métodos para producir los mismos | |
TW200738649A (en) | Calcilytic compounds | |
UA97401C2 (ru) | Экструдат с улучшенной маскировкой вкуса | |
ITTO20060245A1 (it) | Procedimento per la fabbricazione di una biella | |
TW200730521A (en) | Triazine compounds having amino-and carboxyl-containing substituents | |
IL186862A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
BRPI0610156A2 (pt) | forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. | |
MX2009000767A (es) | Sintesis de (2s,5r)-5-etinil-1-{n-(4-metil-1-(4-carboxi-piridin-2- il)piperidin-4-il)glicil}pirrolidina-2-carbonitrilo. | |
UY30023A1 (es) | Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen | |
UY29400A1 (es) | Base libre de lercanidipina. | |
AP2006003858A0 (en) | New association of a sinus node if inhibitor and acalcium inhibitor, and pharmaceutical composition s containing it | |
GT200600010A (es) | Procedimientos para la preparacion de alcoholes aminoetoxibencilicos | |
AR069649A1 (es) | 4-(2,3- difluoro-6-(2- fluoro-4- metil- fenilsulfanil)- fenil)- piperidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20200618 |